InvestigatioN of a Smart Probe for Lung lEsion Characterization Using Impedance Technology - Trial NCT06380361
Access comprehensive clinical trial information for NCT06380361 through Pure Global AI's free database. This phase not specified trial is sponsored by Sensome and is currently Recruiting. The study focuses on Lung Cancer. Target enrollment is 30 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Study Focus
Sponsor & Location
Sensome
Timeline & Enrollment
N/A
Apr 02, 2024
Apr 01, 2025
Primary Outcome
The ability of BioSpy System to acquire electrophysiological measurements in the relevant tissues during bronchoscopic biopsy.
Summary
The objective of the study is to evaluate the feasibility of the BioSpy System sensor to
 differentiate tissues that are encountered during bronchoscopic biopsy of endobronchial
 tumors and peripheral lung nodules and masses.
ICD-10 Classifications
Data Source
ClinicalTrials.gov
NCT06380361
Device Trial